Ho CI - Search Results

1

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity.

Benson SC, Pershadsingh HA, Ho CI, Chittiboyina A, Desai P, Pravenec M, Qi N, Wang J, Avery MA, Kurtz TW. Benson SC, et al. Among authors: ho ci. Hypertension. 2004 May;43(5):993-1002. doi: 10.1161/01.HYP.0000123072.34629.57. Epub 2004 Mar 8. Hypertension. 2004. PMID: 15007034

2

Inhibition of cardiovascular cell proliferation by angiotensin receptor blockers: are all molecules the same?

Benson SC, Iguchi R, Ho CI, Yamamoto K, Kurtz TW. Benson SC, et al. Among authors: ho ci. J Hypertens. 2008 May;26(5):973-80. doi: 10.1097/HJH.0b013e3282f56ba5. J Hypertens. 2008. PMID: 18398340

3

Telmisartan-induced inhibition of vascular cell proliferation beyond angiotensin receptor blockade and peroxisome proliferator-activated receptor-gamma activation.

Yamamoto K, Ohishi M, Ho C, Kurtz TW, Rakugi H. Yamamoto K, et al. Hypertension. 2009 Dec;54(6):1353-9. doi: 10.1161/HYPERTENSIONAHA.109.138750. Epub 2009 Oct 12. Hypertension. 2009. PMID: 19822796 Free PMC article.

4

Molecular and cellular effects of azilsartan: a new generation angiotensin II receptor blocker.

Kajiya T, Ho C, Wang J, Vilardi R, Kurtz TW. Kajiya T, et al. J Hypertens. 2011 Dec;29(12):2476-83. doi: 10.1097/HJH.0b013e32834c46fd. J Hypertens. 2011. PMID: 21986624

5

Design and synthesis of the first generation of dithiolane thiazolidinedione- and phenylacetic acid-based PPARgamma agonists.

Chittiboyina AG, Venkatraman MS, Mizuno CS, Desai PV, Patny A, Benson SC, Ho CI, Kurtz TW, Pershadsingh HA, Avery MA. Chittiboyina AG, et al. Among authors: ho ci. J Med Chem. 2006 Jul 13;49(14):4072-84. doi: 10.1021/jm0510880. J Med Chem. 2006. PMID: 16821769

6

Alpha-Lipoic acid-based PPARgamma agonists for treating inflammatory skin diseases.

Venkatraman MS, Chittiboyina A, Meingassner J, Ho CI, Varani J, Ellis CN, Avery MA, Pershadsingh HA, Kurtz TW, Benson SC. Venkatraman MS, et al. Among authors: ho ci. Arch Dermatol Res. 2004 Aug;296(3):97-104. doi: 10.1007/s00403-004-0480-5. Epub 2004 Jun 24. Arch Dermatol Res. 2004. PMID: 15221328 Free article.

7

Rosiglitazone inhibits proliferation, motility, and matrix metalloproteinase production in keratinocytes.

Bhagavathula N, Nerusu KC, Lal A, Ellis CN, Chittiboyina A, Avery MA, Ho CI, Benson SC, Pershadsingh HA, Kurtz TW, Varani J. Bhagavathula N, et al. Among authors: ho ci. J Invest Dermatol. 2004 Jan;122(1):130-9. doi: 10.1046/j.0022-202X.2003.22111.x. J Invest Dermatol. 2004. PMID: 14962101 Free article.

8

Direct linkage of mitochondrial genome variation to risk factors for type 2 diabetes in conplastic strains.

Pravenec M, Hyakukoku M, Houstek J, Zidek V, Landa V, Mlejnek P, Miksik I, Dudová-Mothejzikova K, Pecina P, Vrbacky M, Drahota Z, Vojtiskova A, Mracek T, Kazdova L, Oliyarnyk O, Wang J, Ho C, Qi N, Sugimoto K, Kurtz T. Pravenec M, et al. Genome Res. 2007 Sep;17(9):1319-26. doi: 10.1101/gr.6548207. Epub 2007 Aug 10. Genome Res. 2007. PMID: 17693571 Free PMC article.

9

Engaging with happy-sounding music promotes helping behavior in 18-month-olds.

Siu TC, Ho CI. Siu TC, et al. Among authors: ho ci. Infancy. 2022 Jan;27(1):197-206. doi: 10.1111/infa.12443. Epub 2021 Nov 17. Infancy. 2022. PMID: 34791778 Clinical Trial.

10

Preparation of fibril nuclei of beta-amyloid peptides in reverse micelles.

Lin YL , Cheng YS , Ho CI , Guo ZH , Huang SJ , Org ML , Oss A , Samoson A , Chan JCC . Lin YL , et al. Among authors: ho ci. Chem Commun (Camb). 2018 Sep 13;54(74):10459-10462. doi: 10.1039/c8cc05882b. Chem Commun (Camb). 2018. PMID: 30156225

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page